Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations business unit, designed to integrate disease expertise ...

Autologous peripheral blood stem cell (PBSC) transplantation has become a standard ... evaluate the CE2 in autologous PBSC collection devices based on pre-apheresis WBC counts. The collection ...

Jerlene Xie never thought that signing up for the Bone Marrow Donor Programme would result in a call from the registry five ...

It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than ...

Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Apheresis machine for extracorporeal elimination ... purification procedure plasma is initially separated from the blood cells. Adding acetate buffer for acidification and heparin to the plasma ...

Aging is inevitable for most cell types in the human body, but hematopoietic stem cells (HSCs) seem to defy the process. They retain their self-renewing ability almost throughout an organism’s ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Pluripotent stem cells are cells that have the capacity to self-renew by dividing and to develop into the three primary germ cell layers of the early embryo and therefore into all cells of the ...

Induced pluripotent stem cells (iPSCs) are pluripotent stem cells generated from adult cells by reprogramming. iPSCs have the same properties as embryonic stem cells, and therefore self-renew and ...